Lesion volume measurement in multiple sclerosis: How important is accurate repositioning?

Journal of Magnetic Resonance Imaging

Volumn 6, Issue 5, 1996, Pages 705-713

  Gawne Cain, Mary L ^a   Webb, Stephanie ^a   Tofts, Paul ^a   Miller, David H ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Lesion load; Magnetic resonance imaging; Multiple sclerosis; Reproducibility

Indexed keywords

ARTICLE; BRAIN; HUMAN; METHODOLOGY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REPRODUCIBILITY;

BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS;

EID: 0030229199     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880060502     Document Type: Article

References (18)

1. Paty DW, Li DKB, the UBC MS/MRI Study Group and The IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993; 43:662-667.
2. Paty DW, Li DK, Oger JJF, et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 1994; 36(suppl):S95-S96.
3. IFNB Multiple Sclerosis Study Group, University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995; 45:1277-1285.
4. Kappos L, Stadt D, Ratzka M, et al. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 1988; 30:299-302.
5. Filippi M, Paty DW, Kappos L, et al. Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995; 45:255-260.
6. Tofts PS, Kermode AG, MacManus DG, Robinson WH. Nasal orientation device to control head movement during CT and MR studies. J Comput Assist Tomogr 1990; 14:163-164.
7. MacManus DG, Kermode AG, Tofts PS. A repositioning technique for cerebral magnetic resonance imaging of patients with multiple sclerosis. Proc Soc Mag Reson 1989; 2:617.
8. Wicks DAG, Barker GJ, Tofts PS. Correction of intensity non-uniformity in MR images of any orientation. Magn Reson Imaging 1993; 11:183-196.
9. Plummer DL. Dispimage: a display and analysis tool for medical images. Riv Neuroradiol 1992; 5:489-495.
10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i:307-310.
11. Grimaud J, Lai M, Thorpe J, et al. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996 (in press).
12. Zar J, ed. Measures of dispersion and variability, 2nd ed. Englewood Cliffs, NJ: Prentice-Hall International Inc., 1984; 27-39.
13. Fleiss JL, ed. The design and analysis of clinical experiments. New York: John Wiley and Sons, 1985.
14. Plante E, Turkstra L. Sources of eror in the quantitative analysis of MRI scans. Magn Reson Imaging 1991; 9:589-595.
15. Clarke LP, Velthuizen RP, Camacho MA, et al. MRI segmentation: methods and applications. Magn Reson Imaging 1995; 13:343-368.
16. Goodkin DE, Ross JS, Vanderbrug Medendorp S, Konecsni J, Rudick RA. Magnetic resonance imaging lesion enlargement in multiple sclerosis. Arch Neurol 1992; 49:261-263.
17. Streiner DL, Norman GR. Reliability. In: Streiner DL, Norman GR, editors. Health measurement scales: a practical guide to their development and use. New York: Oxford University Press, 1995:104-127.
18. Rovaris M, Gawne-Cain ML, Wang L, Miller DH. A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semi-automated contour technique. Neuroradiology 1996 (in press).